It certainly seems like we have drifted away from what i thought was our last stated target, ie blood burne cancers. I think that is a good thing as we should be targetting at least 50 50 fpp applications and cancer/ myc oncology. Will be interesting to see if any developments with genentech when another year goes by in Dec. If they do anything to extend or license that could be a major boost without anything else? I assume any new milestone may be same as or bigger than last, and another 2 mil certainly wouldnt hurt on top of current funding with no dilution.
It certainly seems like we have drifted away from what i thought...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |